-drine
Drugs that mimic adrenaline.
- Drugs ending in -drine: 14
- Approved somewhere: 5
- With a US drug page: 2
- Stem
- -drine
- Class
- Drugs that mimic adrenaline
- Sub-stems
- -frine
- Most common targets
- ADRB2 (2), SLC6A2 (2), Adrenergic receptor alpha-1 (1), Adrenergic receptor (1), HRH1 (1), Glutamate [NMDA] receptor (1), Sodium channel alpha subunit (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -drine or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Midodrine | Approved | Adrenergic receptor alpha-1 | Adrenergic receptor alpha-1 agonist |
| Ritodrine | — | ADRB2 | Beta-2 adrenergic receptor agonist |
| Ephedrine | Approved | Adrenergic receptor | Adrenergic receptor agonist |
| Orphenadrine | Approved | HRH1, SLC6A2, Glutamate [NMDA] receptor, Sodium channel alpha subunit | Histamine H1 receptor antagonist |
| Pseudoephedrine | Approved | SLC6A2 | Norepinephrine transporter releasing agent |
| Bedoradrine | Phase 2 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Cafedrine | Phase 2 | — | — |
| Oxyfedrine | Phase 2 | — | — |
| Oxedrine | — | — | — |
| Propylhexedrine | — | — | — |
| Etilefrine | Approved | — | — |
| Dimetofrine | Phase 2 | — | — |
| Gepefrine | Phase 2 | — | — |
| Norfenefrine | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO